Literature DB >> 9535858

Activation of NF-kappaB is involved in the survival of osteoclasts promoted by interleukin-1.

E Jimi1, I Nakamura, T Ikebe, S Akiyama, N Takahashi, T Suda.   

Abstract

We previously reported that interleukin-1 (IL-1) promoted the survival of murine osteoclast-like cells (OCLs) formed in vitro and activated a transcription factor, NF-kappaB, of OCLs. The present study examined whether the activation of NF-kappaB is directly involved in the survival of OCLs promoted by IL-1. The expression of IL-1 type I receptor mRNA in OCLs was detected by the polymerase chain reaction amplification of reverse-transcribed mRNA. An electrophoretic mobility shift assay showed that IL-1 transiently activated NF-kappaB in the nuclei of the OCLs, and the maximal activation occurred at 30 min. The degradation of IkappaBalpha coincided with the activation of NF-kappaB in the OCLs. The immunocytochemical study revealed that p65, a subunit of NF-kappaB, was translocated from the cytoplasm into almost all of the nuclei of the OCLs within 30 min after IL-1 stimulation. The purified OCLs spontaneously died via apoptosis, and IL-1 promoted the survival of OCLs by preventing their apoptosis. The pretreatment of purified OCLs with proteasome inhibitors suppressed the IL-1-induced activation of NF-kappaB and prevented the survival of OCLs supported by IL-1. When OCLs were pretreated with antisense oligodeoxynucleotides to p65 and p50 of NF-kappaB, the expression of respective mRNAs by OCLs was suppressed, and the IL-1-induced survival of OCLs was concomitantly inhibited. These results indicate that IL-1 promotes the survival of osteoclasts through the activation of NF-kappaB.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9535858     DOI: 10.1074/jbc.273.15.8799

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  35 in total

1.  Osteoprotegerin ligand modulates murine osteoclast survival in vitro and in vivo.

Authors:  D L Lacey; H L Tan; J Lu; S Kaufman; G Van; W Qiu; A Rattan; S Scully; F Fletcher; T Juan; M Kelley; T L Burgess; W J Boyle; A J Polverino
Journal:  Am J Pathol       Date:  2000-08       Impact factor: 4.307

Review 2.  Osteoclasts: New Insights.

Authors:  Xu Feng; Steven L Teitelbaum
Journal:  Bone Res       Date:  2013-03-29       Impact factor: 13.567

Review 3.  Involvement of alpha(v)beta3 integrins in osteoclast function.

Authors:  Ichiro Nakamura; Le T Duong; Sevgi B Rodan; Gideon A Rodan
Journal:  J Bone Miner Metab       Date:  2007-10-25       Impact factor: 2.626

4.  Regulation of osteoclastogenesis by Simon extracts composed of caffeic acid and related compounds: successful suppression of bone destruction accompanied with adjuvant-induced arthritis in rats.

Authors:  Quan Yong Tang; Toshio Kukita; Yuki Ushijima; Akiko Kukita; Kengo Nagata; Ferry Sandra; Toshiyuki Watanabe; Kazuko Toh; Yutaka Okuma; Sadamichi Kawasaki; Linda Rasubala; Junpei Teramachi; Ichiko Miyamoto; Zhou Wu; Tadahiko Iijima
Journal:  Histochem Cell Biol       Date:  2005-10-05       Impact factor: 4.304

5.  Modulation of osteoclastogenesis induced by nucleoside reverse transcriptase inhibitors.

Authors:  George Pan; Michael Kilby; Jay M McDonald
Journal:  AIDS Res Hum Retroviruses       Date:  2006-11       Impact factor: 2.205

6.  Immunolocalization of matrix metalloproteinases and their inhibitors in clinical specimens of bone metastasis from breast carcinoma.

Authors:  S Lhoták; L J Elavathil; S Vukmirović-Popović; W C Duivenvoorden; R G Tozer; G Singh
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

7.  Adriamycin induces myocardium apoptosis through activation of nuclear factor kappaB in rat.

Authors:  Shufeng Li; Mingyan E; Bo Yu
Journal:  Mol Biol Rep       Date:  2007-06-19       Impact factor: 2.316

8.  IL-1alpha stimulates cathepsin K expression in osteoclasts via the tyrosine kinase-NF-kappaB pathway.

Authors:  S Kamolmatyakul; W Chen; S Yang; Y Abe; R Moroi; A M Ashique; Y-P Li
Journal:  J Dent Res       Date:  2004-10       Impact factor: 6.116

9.  Reduced miR-9 and miR-181a expression down-regulates Bim concentration and promote osteoclasts survival.

Authors:  Shilong Wang; Chaoliang Tang; Quan Zhang; Wenjun Chen
Journal:  Int J Clin Exp Pathol       Date:  2014-04-15

10.  Absence of platelet-activating factor receptor protects mice from osteoporosis following ovariectomy.

Authors:  Hisako Hikiji; Satoshi Ishii; Hideo Shindou; Tsuyoshi Takato; Takao Shimizu
Journal:  J Clin Invest       Date:  2004-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.